1. The UK government hosted the Global Vaccine Summit on June 4, 2020 under the patronage of the  Boris Johnson, Prime Minister of the United Kingdom of Great Britain and Northern Ireland. The meeting was held by videoconference in light of the ongoing COVID-19 pandemic.
2. The funding will help immunise 300 million more children in lower-income countries against diseases like measles, polio and diphtheria by the end of 2025. It will also support health systems to withstand the impact of coronavirus and maintain the infrastructure necessary to roll out a future COVID-19 vaccine on a global scale.
3. The Summit brought together more than 300 people, including 42 Heads of States and Governments. 52 countries were represented, notably 14 Gavi implementing countries, all of the G7 nations and 19 governments of the G20. Also many business leaders, UN agencies, civil society, government ministers, Heads of State and country leaders participated.

   Eminent participants also included H.E. Antonio Guterres, Secretary-General of the United Nations;  H.E. Dr Tedros Adhanom Ghebreyesus, WHO Director-General; H.E. Henrietta Fore, UNICEF Executive Director; Bill Gates, Co-Chair of the Bill & Melinda Gates Foundation; Ministers from implementing and donor countries; CEOs of vaccine manufacturing companies and private sector partners; leaders of UN and other international agencies; senior civil society representatives; and Gavi champions.

4. India pledged 15 Million US Dollars to Gavi, the international vaccine alliance.
5. Besides receiving strong endorsements from long-standing Gavi donors, the Summit welcomed eight new sovereign donors who made pledges to Gavi for the first time, including Bhutan, Burkina Faso, Cameroon, Finland, Greece, New Zealand, Portugal and Uganda.
6. Participants also welcomed new commitments made by the pharmaceutical industry to further invest in R&D and production and supply a range of vaccines in significant quantities to Gavi
7. The Summit also discussed the global response to COVID-19. Kate Bingham, Head of the UK Vaccine Task Force, set out the challenges and opportunities that a vaccine against COVID-19 would present.
8. Dr Berkley announced the launch of the COVID-19 Global Vaccine Access Facility (COVAX Facility). Its objective is to accelerate equitable access to appropriate, safe and efficaciousCOVID- 19 vaccines for all countries. Higher income countries will use domestic resources to contribute funds to the advance purchase guarantees and will purchase vaccines side by side with Gavi- supported countries who will use ODA resources. Manufacturers’ interest was recognized, as producers are seeking volume guarantees to scale production and understanding the risk of only serving a few countries in times of global pandemic and want to work with the Facility. AstraZeneca made the first private sector commitment to the Covax facility with 300 million doses of vaccine if it is successful guaranteed for the COVAX Facility.
9. Covax, is a new innovative financing instrument to provide access to COVID-19 vaccines for low- and middle-income countries. This is the first building block towards a global mechanism to ensure equitable access to future COVID-19 vaccines.

About GAVI